Topical Agent for Treatment of Red Skin

Proof of Concept Trial:SR-01 for the Treatment of Rosacea

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00279890

Enrollment

Registered

2006-01-20

Start date

2005-07-31

Completion date

2007-01-31

Last updated

2011-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilaterally Symmetric Red Skin on Cheeks, Rosacea

Brief summary

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

Interventions

DRUGTopical SR-01

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

Bilaterally symmetric red skin on cheeks Caucasian Age 18-60 years

Design outcomes

Primary

Measure	Time frame
Reduction of redness	—

Secondary

Measure	Time frame
Safety and tolerability	—
Cosmetic acceptability	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026